Tempus AI Inc
For the period ended Dec 31, 2024. Filed Feb 24, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 24, 2025
TEM$80.54-4.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
(in thousands, except per share amounts)
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net revenue | |||
| Genomics | $451,749 | $363,022 | $197,984 |
| Data and services | 241,649 | 168,800 | 122,684 |
| Total net revenue | $693,398 | $531,822 | $320,668 |
| Cost and operating expenses | |||
| Cost of revenues, genomics | 243,467 | 189,165 | 150,255 |
| Cost of revenues, data and services | 68,818 | 56,482 | 40,227 |
| Technology research and development | 167,519 | 95,155 | 79,093 |
| Research and development | 149,325 | 90,343 | 83,158 |
| Selling, general and administrative | 755,351 | 296,760 | 233,377 |
| Total cost and operating expenses | 1,384,480 | 727,905 | 586,110 |
| Loss from operations | $(691,082) | $(196,083) | $(265,442) |
| Interest income | 11,084 | 7,601 | 3,032 |
| Interest expense | (53,653) | (46,869) | (21,894) |
| Other income (expense), net | 32,336 | 21,822 | (4,846) |
| Loss before provision for income taxes | $(701,315) | $(213,529) | $(289,150) |
| Provision for income taxes | (266) | (288) | (66) |
| Losses from equity method investments | (4,228) | (301) | (595) |
| Net Loss | $(705,809) | $(214,118) | $(289,811) |
| Accretion of convertible preferred stock to redemption value | — | (4,338) | (301) |
| Dividends on Series A, B, B-1, B-2, C, D, E, F, G, G-3, and G-4 preferred shares | (39,347) | (44,497) | (40,975) |
| Cumulative undeclared dividends on Series C preferred shares | (1,174) | (3,011) | (2,841) |
| Net loss attributable to common shareholders, basic and diluted | (746,330) | (265,964) | (333,928) |
| Net loss per share attributable to common shareholders, basic and diluted | $(6.23) | $(4.20) | $(5.30) |
| Weighted-average shares outstanding used to compute net loss per share, basic and diluted | 119,849 | 63,306 | 63,032 |
| Comprehensive Loss, net of tax | |||
| Net loss | $(705,809) | $(214,118) | $(289,811) |
| Foreign currency translation adjustment | 89 | (13) | 29 |
| Comprehensive loss | $(705,720) | $(214,131) | $(289,782) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.